18 commercial payer policies list J0741. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
18 policies from 12 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J0741 |
|---|---|---|
| Cabenuva (cabotegravir and rilpivirine extended-release injectable suspension) | Not recorded | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Cabenuva (cabotegravir and rilpivirine extended-release injectable suspension)Effective 05/01/2024 - 04/30/2025 | May 1, 2024 | Prior auth requiredInferred from policy title |
| Cabenuva (cabotegravir and rilpivirine extended-release injectable suspension)Effective 05/01/2025 - 04/30/2026 | May 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Cabotegravir and Rilpivirine (Cabenuva)Effective 06/01/2021 - 07/31/2022 | Jun 1, 2021 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Cabotegravir and Rilpivirine (Cabenuva)Effective 06/01/2023 - 04/30/2024 | Jun 1, 2023 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Cabotegravir and Rilpivirine (Cabenuva)Effective 08/01/2022 - 05/31/2023 | Aug 1, 2022 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J0741 |
|---|---|---|
| Cabenuva (cabotegravir and rilpivirine) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| State and School Employees' Health Insurance Plan - Cabenuva (cabotegravir and rilpivirine) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0741 |
|---|---|---|
| Cabotegravir extended release – rilpivirine extended release (e.g., Cabenuva) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0741 |
|---|---|---|
| Long-Acting Injectable Antiretroviral Agents for Treatment of HIV | Apr 1, 2026 | Covered |
| Policy | Effective | Status of J0741 |
|---|---|---|
| Long-Acting Injectable Antiretroviral Agents for Treatment of HIV | Apr 1, 2026 | Covered |
| Policy | Effective | Status of J0741 |
|---|---|---|
| Long-Acting Injectable Antiretroviral Agents for Treatment of HIV | Apr 1, 2026 | Covered |
| Policy | Effective | Status of J0741 |
|---|---|---|
| Long-Acting Injectable Antiretroviral Agents for Treatment of HIV | Apr 1, 2026 | Covered |
| Policy | Effective | Status of J0741 |
|---|---|---|
| CABENUVA (CABOTEGRAVIR + RILPIVIRINE) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0741 |
|---|---|---|
| Cabotegravir, Cabotegravir-Rilpivirine (Apretude, Cabenuva); CP.PHAR.573 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0741 |
|---|---|---|
| Long-Acting Injectable Antiretroviral Agents for HIV | Oct 1, 2025 | Covered |
| Policy | Effective | Status of J0741 |
|---|---|---|
| Long-Acting Injectable Antiretroviral Agents for HIV | Oct 1, 2025 | Covered |
| Policy | Effective | Status of J0741 |
|---|---|---|
| Long-Acting Injectable Antiretroviral Agents for HIV | Oct 1, 2025 | Covered |